← Every company
Arcutis Biotherapeutics Inc Planned Sales
Before an insider at Arcutis Biotherapeutics Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
ARQT insider trades →Notices on file
2
Insiders
2
Shares noticed
346.7K
permission to sell, not sales
Estimated value
$8.7M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Todd Edwards LarryFormer Officer2026-09-16342K sh0.27% | $8.5M |
| Welgus HowardDirector2026-09-154.7K sh<0.01% | $114.4K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on ARQT
Company overviewEverything on ARQT in one place, with the price.SEC filingsWhat ARQT's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ARQT's own officers and directors buy and sell.Executive payWhat ARQT awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ARQT.Funds holding itWhich funds and ETFs hold ARQT, and how big a bet.LobbyingWhat ARQT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ARQT's account, and who they worked for.PatentsWhat ARQT is filing at the patent office.